DVT

SonoVascular Enters into Strategic Collaboration with Lantheus Holdings, Inc. for Use of Microbubbles in Combination with SonoThrombectomy™ System for Treatment of Venous Thromboembolism

Retrieved on: 
Thursday, May 2, 2024

VTE is a condition that occurs when a blood clot forms in a deep vein, resulting in DVT.

Key Points: 
  • VTE is a condition that occurs when a blood clot forms in a deep vein, resulting in DVT.
  • The microbubbles are activated by intravascular ultrasound and will be investigated in ongoing pre-clinical and upcoming clinical studies.
  • The SonoThrombectomy System has been engineered to address and overcome the deficiencies and limitations of current interventional devices.
  • Additionally, upon completion of a FIH study, SonoVascular has an option to enter into a long-term exclusive commercial supply agreement with Lantheus.

Coinstore New Public Chain Forum “Finding the Future Alpha” Has Completed Successfully

Retrieved on: 
Monday, April 22, 2024

Singapore, April 22, 2024 (GLOBE NEWSWIRE) -- Global top crypto asset platform, Coinstore, held a new public chain forum called “Finding the Future Alpha - Will Solana lead the next boom? ''

Key Points: 
  • Singapore, April 22, 2024 (GLOBE NEWSWIRE) -- Global top crypto asset platform, Coinstore, held a new public chain forum called “Finding the Future Alpha - Will Solana lead the next boom? ''
  • Before the forum, Coinstore has rich experience in holding events,and has actively published Cryptalk and CS Connect events.To date, Coinstore held more than 30 Cryptalk, nearly 40 CS Connect and 22 Expo conferences.
  • This public chain forum will become a benchmark forum.
  • Coinstore will hold more forums and events in the future to promote the collision of technology, capital, and new ideas, and bring innovation to the crypto industry.

Keysight Secures New Test Case Validations for Narrowband Non-Terrestrial Networks Standard

Retrieved on: 
Monday, April 29, 2024

The new NB-IoT NTN conformance test case validations cover transmitter and receiver, demodulation, and radio resource management (RRM).

Key Points: 
  • The new NB-IoT NTN conformance test case validations cover transmitter and receiver, demodulation, and radio resource management (RRM).
  • These test case validations also enable Keysight to support certification testing at GCF Recognized Test Organizations (RTO).
  • The test cases are managed through the Keysight ATLAS Test Management Center , the company’s new framework for automated acceptance testing.
  • Notable test case validations included RRM RedCap for single receiver and inter-radio access technology with EUTRA.

Avalanche Technology Achieves ISO 9001:2015 Certification, Demonstrating Commitment to Quality Assurance and Technological Excellence

Retrieved on: 
Monday, April 15, 2024

FREMONT, Calif., April 15, 2024 /PRNewswire-PRWeb/ -- Avalanche Technology, the leader in next generation MRAM technology, has earned its ISO 9001:2015/Full Design certification, effective immediately. The certification reflects Avalanche's exceptional quality assurance processes. Perry Johnson Registrars, a leading expert in the testing, inspection, and certification sector, conducted the rigorous assessment. Registrar founder Perry L. Johnson is one of the world's foremost authorities in quality, having written more than 15 manuals covering topics from Total Quality Management to Statistical Process Control and ISO/QS-9000.

Key Points: 
  • The ISO 9001 designation is the world's most widely recognized quality management standard (QMS), set by the International Organization of Standardization in Geneva, Switzerland.
  • Avalanche's approach to achieving high quality includes many disciplines and processes:
    Reliability certification of technology development at Avalanche foundries.
  • The technical complexity in addressing these challenges shows the value of ISO 9001 certification, where quality underscores all development processes.
  • For more information on how Avalanche is meeting its commitment to this standard, read about Avalanche's approach to quality .

National Blood Clot Alliance Names Corewell Health a Center of Excellence

Retrieved on: 
Wednesday, April 10, 2024

PHILADELPHIA, April 10, 2024 /PRNewswire/ -- National Blood Clot Alliance ® (NBCA) today announced that Corewell Health™ Grand Rapids Hospitals – Butterworth Hospital has been named the inaugural NBCA Center of Excellence in the United States.

Key Points: 
  • PHILADELPHIA, April 10, 2024 /PRNewswire/ -- National Blood Clot Alliance ® (NBCA) today announced that Corewell Health™ Grand Rapids Hospitals – Butterworth Hospital has been named the inaugural NBCA Center of Excellence in the United States.
  • By designating Corewell Health a Center of Excellence, we are acknowledging its commitment to both clinical excellence and patient education," said Board Member and NBCA Committee Chair Justin Crockett.
  • In designating Corewell Health as an NBCA Center of Excellence, the committee highlighted both the qualitative and quantitative multidisciplinary, systematic approach to DVT and PE treatment.
  • "This formal recognition speaks highly of the demonstrated excellence of Corewell Health's program treating patients with acute and chronic VTE," said Alejandro Quiroga, M.D., president, Corewell Health in West Michigan.

Award-winning Director Kurosawa Kiyoshi Pioneers Theater-to-Web3 Movie Distribution Model with Intertrust Supertickets on Nekojarashi’s Roadstead.io

Retrieved on: 
Tuesday, April 9, 2024

Nekojarashi, Inc. and Intertrust today announced they will debut Chime, a film by celebrated director, Kurosawa Kiyoshi, through a unique Web3 collaboration on Nekojarashi’s Digital Video Trading (DVT) Platform, Roadstead.io .

Key Points: 
  • Nekojarashi, Inc. and Intertrust today announced they will debut Chime, a film by celebrated director, Kurosawa Kiyoshi, through a unique Web3 collaboration on Nekojarashi’s Digital Video Trading (DVT) Platform, Roadstead.io .
  • Superticket purchasers will have exclusive rights to Chime, which will be available worldwide on April 12, 2024, Japan Standard Time.
  • In an unprecedented move for a Kurosawa film, Chime introduces a unique viewing experience through limited-edition Supertickets, available only for a month post-opening.
  • It is a crazy movie, a bizarre movie, and that is what this film is about,” said Kurosawa Kiyoshi.

Clarius and ThinkSono Introduce a New AI-Guided Ultrasound System Enabling Rapid Assessments of DVTs

Retrieved on: 
Friday, April 5, 2024

VANCOUVER, BC, April 5, 2024 /PRNewswire/ -- Clarius Mobile Health, a leading provider of high-definition handheld ultrasound systems, and ThinkSono, a pioneering medical technology company specializing in ultrasound artificial intelligence (AI) guidance solutions, are introducing a new AI-guided ultrasound system in Europe, which will improve the efficiency of detecting deep vein thrombosis (DVT). ThinkSono Guidance, an AI App that pairs with Clarius ultrasound scanners, recently attained Class llb CE mark regulatory approval.

Key Points: 
  • ThinkSono Guidance, an AI App that pairs with Clarius ultrasound scanners, recently attained Class llb CE mark regulatory approval.
  • ThinkSono Guidance enables non-ultrasound trained healthcare professionals to use the Clarius handheld ultrasound scanner to collect DVT exam data for a qualified clinician to review.
  • ThinkSono now uses Clarius' Solum software development kit (SDK), enabling the company to create a bespoke solution tailored to their DVT application.
  • The Clarius SDK suite empowers third party developers to seamlessly integrate AI-powered ultrasound software with Clarius handheld ultrasound systems, the Clarius App, and the Clarius Cloud exam management platform.

Restaking Platform PrimeStaked Reopens Deposits Following $40M in Demand

Retrieved on: 
Tuesday, March 12, 2024

Origin Protocol , a leading DeFi platform, has announced the remarkable success of a newly launched liquid restaking platform, PrimeStaked , which has achieved a Total Value Locked (TVL) milestone of over $40 million and has just reopened deposits with added support for ETH restaking.

Key Points: 
  • Origin Protocol , a leading DeFi platform, has announced the remarkable success of a newly launched liquid restaking platform, PrimeStaked , which has achieved a Total Value Locked (TVL) milestone of over $40 million and has just reopened deposits with added support for ETH restaking.
  • Built on top of EigenLayer, the platform has attracted $35+ million in OETH deposits on PrimeStaked and $80 million of total OETH deposits on EigenLayer.
  • On March 11, PrimeStaked opened support for native ETH restaking, which will accept deposits on an ongoing basis.
  • PrimeStaked has partnered with P2P.org, a staking provider with $1B+ in AUM, and ssv.network, a distributed validator technology (DVT), to support ETH deposits for liquid restaking.

Inari Medical Announces Interim Two-Year Results from the ClotTriever CLOUT Registry

Retrieved on: 
Tuesday, March 12, 2024

IRVINE, Calif., March 12, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) a medical device company focused on developing products to treat and transform the lives of patients suffering from venous and other diseases, announced positive two-year interim results from the CLOUT registry.

Key Points: 
  • IRVINE, Calif., March 12, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) a medical device company focused on developing products to treat and transform the lives of patients suffering from venous and other diseases, announced positive two-year interim results from the CLOUT registry.
  • The interim results are the largest prospective, multi-center two-year dataset in deep vein thrombosis (DVT) since the ATTRACT trial and confirm the excellent safety, effectiveness, and long-term outcomes of the ClotTriever system in real-world DVT patients.
  • Patients had low incidence of independently adjudicated safety events related to rethrombosis, with only 5.0% and 8.4% at 30-days and 6 months, respectively.
  • We remain committed to establishing the ClotTriever and FlowTriever systems as standard of care for deep vein thrombosis and pulmonary embolism (PE) patients.”

Sky Harbour Group Corporation Announces its 2023 Financial Results; Updates on New Ground Leases, Construction and Hangar Leasing; Injects Equity into Obligated Group and Files Various Registration Statements with SEC

Retrieved on: 
Wednesday, March 27, 2024

New ground lease at SJC, encompassing an existing hangar facility to be made operational over the coming several weeks, and land for additional future development.

Key Points: 
  • New ground lease at SJC, encompassing an existing hangar facility to be made operational over the coming several weeks, and land for additional future development.
  • New ground lease at ORL, with expected construction commencement in Q2 2025.
  • Construction of Phases 1 in Denver, Phoenix, and Dallas delayed by 3-4 months, with an estimated $26 - $28 million non-recurring remediation cost.
  • We are now gearing up to perform at scale.”
    Sky Harbour will host a live conference call and concurrent webcast at 5 p.m.